Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Divis Laboratories
Divis Laboratories
Activities:
Manufacturing
Trending Articles
From data to decisions: applying criticality and failure probability in process risk mitigation
This article presents an exploration of how structured, data-based methods enhance quality control, optimise specifications and improve process robustness throughout the...
You need to be a subscriber to read this article.
Click here
to find out more.
Stop reviewing good data: review‑by‑exception for chromatography QC
Labs spend hours confirming routine chromatograms while real risks hide in plain sight; regulators support a better path if data are captured and surfaced correctly, notes...
SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production
The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...
Manufacturing Chemist Stand Side with GEA and Hovione
We discover what exhibitors at CPHI 2025 are showcasing LIVE!
Vileda Professional CE launches revolutionary single-use microfibre mopping system
Vileda Professional CE launches revolutionary single-use microfibre mopping system for cleanrooms and controlled environments
Upcoming event
From powder to granules: a deep dive into wet granulation methods
14 January 2026 | Virtual
See all
Related Content
Manufacturing
Juniper selected for network infrastructure across manufacturing facilities
A Juniper-powered network enables Divi's Labs to realise enhanced operational efficiencies and improved network experiences for its workforce of over 17,000 employees
Finance
Indian drug companies expected to sustain margin improvement
India business is bouncing back aided by favourable exchange rates
Ingredients
Indian API market on the up as domestic drug prices fall
Indian API manufacturers are branching out into new markets, while international suppliers could be hit by lower prices in the domestic market, writes Asia correspondent A Nair
Subscribe now